FDA Advisory Committee to Review GRAIL's Galleri Multi-Cancer Detection Test
Hepatitis B Surface Antigen (HBsAg) Testing: Understanding Your Results
Hepatitis B surface antigen (HBsAg) is a protein found on the surface of the hepatitis B virus. When someone is infected with hepatitis B, this antigen appears in the bloodstream and can be detected through laboratory testing. The HBsAg test is one of the most important screening tools for diagnosing hepatitis B infection, whether it is acute (recent) or chronic (long-term). Healthcare providers commonly order this test when evaluating patients for possible hepatitis B exposure or when screening individuals at higher risk for infection.
The presence of HBsAg in the blood indicates an active hepatitis B infection. If the test result is positive, it means the virus is currently present in your body. In acute infections, HBsAg typically appears within one to ten weeks after exposure to the virus and disappears within four to six months if the person recovers. However, if HBsAg remains detectable in the blood for more than six months, this suggests the infection has become chronic. Chronic hepatitis B can lead to serious liver complications over time, including cirrhosis and liver cancer, which is why ongoing monitoring is essential.
A negative HBsAg result generally means you do not have an active hepatitis B infection at the time of testing. However, healthcare providers often order additional tests alongside HBsAg to get a complete picture of your hepatitis B status. These may include antibody tests that show whether you have immunity from vaccination or past infection, or tests for hepatitis B core antibodies that can detect previous exposure. Your doctor may also order liver function tests and hepatitis B viral load measurements to assess liver health and the extent of viral activity if you test positive.
Understanding your HBsAg test results is crucial for appropriate medical care and preventing transmission to others. People who test positive should work closely with their healthcare providers to monitor liver function and discuss treatment options if necessary. They should also take precautions to prevent spreading the virus to family members and sexual partners. Regular screening is recommended for individuals at increased risk, including healthcare workers, people with multiple sexual partners, injection drug users, and those living with someone who has hepatitis B.
magyar
română
slovenčina
čeština
English
Deutsch
polski
italiano
español
svenska
português
français
dansk
suomi
Nederlands